LET Gel 4% (Lidocaine HCl 4% + EPINEPHrine HCl 0.05% + Tetracaine HCl 0.5%), 3mL Single Use Syrin...

FDA Drug Recall #D-0482-2019 — Class II — January 24, 2019

Recall Summary

Recall Number D-0482-2019
Classification Class II — Moderate risk
Date Initiated January 24, 2019
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm US Compounding Inc
Location Conway, AR
Product Type Drugs
Quantity 1931 syringes

Product Description

LET Gel 4% (Lidocaine HCl 4% + EPINEPHrine HCl 0.05% + Tetracaine HCl 0.5%), 3mL Single Use Syringe, Rx only, US Compounding, 1270 Don's Lane, Conway, AR, 800-718-3588, Barcode 62295501303.

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp Date: Labels are missing lot and expiration date and are printed as Lot# YYYDDYY@XX with a Beyond Use Date: MM/DD/YYY.

Distribution Pattern

Nationwide in the USA.

Lot / Code Information

Labeled as Lot# YYYDDYY@XX, Beyond Use Date: MM/DD/YYYY.

Other Recalls from US Compounding Inc

Recall # Classification Product Date
D-0223-2021 Class III Succinylcholine Chloride PF Inj. 200 mg/10 mL, ... Dec 16, 2020
D-0175-2021 Class III Neostigmine Methylsulfate PF Inj. 5 mg/5 mL, 5 ... Nov 25, 2020
D-0508-2019 Class II Ephedrine Sulfate, 50 mg/10 mL, 10 mL Single Us... Jan 29, 2019
D-0219-2017 Class I Docusate Oral 10 mg/mL Oral Syringe, packaged i... Jul 25, 2016
D-0254-2016 Class II HCG/B12 (5,000 units, 0.6 mg) 5 mL, Multi-Dose ... Sep 12, 2015

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.